发明名称 |
Methods for treating lysosomal acid lipase deficiency |
摘要 |
The present invention provides compositions and methods for effective treatment of a lysosomal acid lipase deficiency (LALD) disease, in particular, Wolman's disease and Cholesteryl Ester Storage Disease (CESD). Among other things, the present invention provides a method of treating developmental impairment or malnutrition in an individual suffering from a lysosomal acid lipase deficiency (LALD) disease, comprising administering to the individual a therapeutic effective amount of a lysosomal acid lipase. |
申请公布号 |
US8945542(B2) |
申请公布日期 |
2015.02.03 |
申请号 |
US201313967050 |
申请日期 |
2013.08.14 |
申请人 |
Synageva Biopharma Corp. |
发明人 |
Heartlein Michael;Concino Michael;Martini Paolo;Meiyappan Muthuraman;Calias Pericles;Romashko Alla;Pescatore Brian;Charnas Lawrence;Powell Jan;Felice Brian;Savioli Nancy |
分类号 |
A61K38/46 |
主分类号 |
A61K38/46 |
代理机构 |
McDermott Will & Emery LLP |
代理人 |
McDermott Will & Emery LLP |
主权项 |
1. A method of treating a lysosomal acid lipase deficiency (LALD) disease, comprising administering subcutaneously to an individual suffering from or susceptible to the LALD disease a therapeutically effective amount of a lysosomal acid lipase periodically at an administration interval, wherein a therapeutically effective amount of lysosomal acid lipase for the subcutaneous administration is about 5-fold more than a therapeutically effective amount of lysosomal acid lipase for intravenous administration. |
地址 |
Lexington MA US |